-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at Fi South America 2025
Category:
发布时间：2025-08-28
【概要描述】
On August 26, local time, at the Shijiazhuang Sihua Pharmaceutical Group’s booth in the Pan-American Convention and Exhibition Center in São Paulo, Brazil, international buyers and trade representatives eagerly inquired with the company’s foreign-trade staff about the firm and its product offerings. The Fi South America 2025 Food Ingredients Exhibition was held here from August 26 to 28. Shijiazhuang Sihua Pharmaceutical Group’s API export team, together with its subsidiaries Hebei Guangxiang Pharmaceutical Co., Ltd. and Hebei Guolong Pharmaceutical Co., Ltd., showcased key API products at the show and actively sought to expand into the South American market.
On August 26, local time, at the Shijiazhuang Sihua Pharmaceutical Group booth in the São Paulo Expo Convention Center in Brazil, international buyers and trade professionals eagerly sought information from the company’s foreign-trade staff about the firm and its products. The Fi South America 2025 Food Ingredients Exhibition was held here from August 26 to 28, during which Shijiazhuang Sihua Pharmaceutical’s API export team, together with its subsidiaries Hebei Guangxiang Pharmaceutical Co., Ltd. and Hebei Guolong Pharmaceutical Co., Ltd., showcased key API products and actively pursued market expansion in South America.
According to reports, Fi South America 2025—the South American Food Ingredients Exhibition—is the largest and most influential event in the region’s food ingredients industry. This year’s show spans 24,000 square meters, bringing together more than 400 exhibitors from around the world and is expected to attract over 15,000 professional visitors.
At the exhibition, the Group’s bulk and specialty APIs—including caffeine, theophylline, and azithromycin—attracted extensive attention from buyers in Brazil, Uruguay, Argentina, and other regions. In particular, the caffeine API that recently obtained EU CEP certification has significantly enhanced the Group’s brand presence in the South American market.
The Group’s API export team fully capitalized on the trade fair to meticulously promote the unique features of its products and the company’s development prospects, while leveraging the extensive product portfolio cultivated through the Group’s accelerated integration of API and formulation operations in recent years to aggressively tap into the South American market. On the first day of the exhibition, the team engaged in discussions and exchanges with nearly 20 existing and new customers, resulting in the identification of several potential business cooperation opportunities.
In recent years, the Group has been driven by innovation to optimize its product portfolio and accelerate the integration of API and formulation operations. Leveraging its advantages in digital and intelligent manufacturing as well as a green supply chain, the Group has steadily expedited international certifications and quality audits for key products, thereby supporting its expansion into overseas markets. According to the Group’s head of foreign trade, the company will continue to deepen its “going global” strategy and further enhance its influence in the South American API market.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091